13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001404574
Total reported value
$2.0B
$2.0B
127 檔
18.5%
During the Q1 2025 filing period, 683 Capital Management, LLC (CIK: 0001404574) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $2.0B across 127 reported positions.
In Q1 2025, 683 Capital Management, LLC displayed an active expansion posture, initiating 127 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 6.98% | +1.92% | -46.74% | |
| 2 | TSLA | Tesla Inc | Stock-Consumer Disc | 6.09% | -2.13% | EXIT | |
| 3 | COF | Capital One Financial CORP | Stock-Financials | 5.36% | +0.03% | +17.03% | |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 4.01% | -0.09% | +12.91% | |
| 5 | MSTR | Strategy Inc | Stock-Tech | 3.62% | -0.31% | +15.69% | |
| 6 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 3.03% | -3.87% | — | |
| 7 | GXO | Gxo Logistics Inc | Stock-Industrials | 2.56% | -0.81% | +46.15% | |
| 8 | INSM 0.75 06-01-28Bond | Insmed Inc | Bond | 2.51% | — | — | |
| 9 | CVNA | Carvana Co | Stock-Consumer Disc | 2.48% | -0.12% | -23.56% | |
| 10 | WVE | Wave Life Sciences Ltd. | Stock-Other | 2.19% | -0.44% | +3.70% | |
| 11 | HGV | Hilton Grand Vacations Inc | Stock-Other | 1.98% | +0.19% | -19.37% | |
| 12 | BBIO 2.5 03-15-27Bond | Bridgebio Pharma Inc | Bond | 1.95% | -0.15% | — | |
| 13 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 1.93% | -0.17% | +11.81% | |
| 14 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 1.88% | +0.20% | — | |
| 15 | PM | Philip Morris International | Stock-Consumer Staples | 1.75% | — | — | |
| 16 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 1.67% | -0.29% | +21.95% | |
| 17 | ERO | Ero Copper CORP | Stock-Other | 1.50% | — | -27.06% | |
| 18 | AMTM | Amentum Holdings Inc | Stock-Industrials | 1.40% | +0.07% | +161.88% | |
| 19 | WDC | Western Digital CORP | Stock-Tech | 1.39% | — | +13.79% | |
| 20 | AB | Alliancebernstein Holding LP | Stock-Other | 1.39% | — | — | |
| 21 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 1.37% | — | -9.45% | |
| 22 | LDOS | Leidos Holdings Inc | Stock-Tech | 1.31% | — | — | |
| 23 | CCOI | Cogent Communications Holdin | Stock-Other | 1.25% | -0.93% | EXIT | |
| 24 | MGTX | MeiraGTx Holdings plc | Stock-Other | 1.20% | +0.42% | +6.63% | |
| 25 | COIN | Coinbase Global Inc -class A | Stock-Financials | 1.20% | +0.07% | — | |
| 26 | HES | Hess CORP | Stock-Other | 1.18% | — | — | |
| 27 | SAIC | Science Applications Inte | Stock-Tech | 1.15% | -0.09% | EXIT | |
| 28 | KBR | Kbr Inc | Stock-Industrials | 1.14% | — | — | |
| 29 | QURE | uniQure N.V. | Stock-Other | 1.13% | +0.52% | +1.64% | |
| 30 | BIDU | Baidu Inc - Spon Adr | Stock-Comm Services | 1.13% | — | +4.41% | |
| 31 | CNC | Centene CORP | Stock-Healthcare | 1.11% | — | — | |
| 32 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 0.95% | -0.46% | -12.78% | |
| 33 | INSE | Inspired Entertainment Inc | Stock-Other | 0.92% | -0.22% | -8.03% | |
| 34 | LEN | Lennar Corp-a | Stock-Consumer Disc | 0.87% | +0.19% | +12.82% | |
| 35 | LEN-B | Lennar CORP - B Shs | Stock-Other | 0.87% | -0.50% | EXIT | |
| 36 | ELV | Elevance Health Inc | Stock-Healthcare | 0.81% | +0.15% | — | |
| 37 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 0.80% | +0.03% | -57.68% | |
| 38 | PDD | Pdd Holdings Inc | Stock-Consumer Disc | 0.78% | — | — | |
| 39 | KNOP | KNOT Offshore Partners LP | Stock-Other | 0.78% | -0.04% | — | |
| 40 | CZR | Caesars Entertainment Inc | Stock-Consumer Disc | 0.73% | -0.21% | EXIT | |
| 41 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.73% | -0.16% | +61.76% | |
| 42 | XHR | Xenia Hotels & Resorts Inc | Stock-Other | 0.72% | -0.04% | EXIT | |
| 43 | 2662247D | Iteos Therapeutics Inc | Stock-Other | 0.72% | — | +90.61% | |
| 44 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.72% | -0.03% | +1.87% | |
| 45 | ASML | ASML Holding N.V. | Stock-Tech | 0.72% | — | — | |
| 46 | HRMY | Harmony Biosciences Holdings | Stock-Other | 0.69% | +0.53% | — | |
| 47 | MRP | Millrose Properties | Stock-Real Estate | 0.65% | — | — | |
| 48 | ZVRA | Zevra Therapeutics Inc | Stock-Other | 0.63% | +0.13% | — | |
| 49 | CRESY | Cresud S.a.-spons Adr | Stock-Other | 0.63% | -0.13% | -6.21% | |
| 50 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.62% | -0.08% | +40.98% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 2 | TSLA | Tesla Inc | — | NEW | New buy |
| 3 | COF | Capital One Financial CORP | — | NEW | New buy |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | — | NEW | New buy |
| 5 | MSTR | Strategy Inc | — | NEW | New buy |
| 6 | PLTR | Palantir Technologies Inc-a | — | NEW | New buy |
| 7 | GXO | Gxo Logistics Inc | — | NEW | New buy |
| 8 | INSM 0.75 06-01-28Bond | Insmed Inc | — | NEW | New buy |
| 9 | CVNA | Carvana Co | — | NEW | New buy |
| 10 | WVE | Wave Life Sciences Ltd. | — | NEW | New buy |
| 11 | HGV | Hilton Grand Vacations Inc | — | NEW | New buy |
| 12 | BBIO 2.5 03-15-27Bond | Bridgebio Pharma Inc | — | NEW | New buy |
| 13 | NVO | Novo-nordisk A/s-spons Adr | — | NEW | New buy |
| 14 | UNH | Unitedhealth Group Inc | — | NEW | New buy |
| 15 | PM | Philip Morris International | — | NEW | New buy |
| 16 | PTGX | Protagonist Therapeutics Inc | — | NEW | New buy |
| 17 | ERO | Ero Copper CORP | — | NEW | New buy |
| 18 | AMTM | Amentum Holdings Inc | — | NEW | New buy |
| 19 | WDC | Western Digital CORP | — | NEW | New buy |
| 20 | AB | Alliancebernstein Holding LP | — | NEW | New buy |
| 21 | BBIO | Bridgebio Pharma Inc | — | NEW | New buy |
| 22 | LDOS | Leidos Holdings Inc | — | NEW | New buy |
| 23 | CCOI | Cogent Communications Holdin | — | NEW | New buy |
| 24 | MGTX | MeiraGTx Holdings plc | — | NEW | New buy |
| 25 | COIN | Coinbase Global Inc -class A | — | NEW | New buy |
| 26 | HES | Hess CORP | — | NEW | New buy |
| 27 | SAIC | Science Applications Inte | — | NEW | New buy |
| 28 | KBR | Kbr Inc | — | NEW | New buy |
| 29 | QURE | uniQure N.V. | — | NEW | New buy |
| 30 | BIDU | Baidu Inc - Spon Adr | — | NEW | New buy |
| 31 | CNC | Centene CORP | — | NEW | New buy |
| 32 | ALNY | Alnylam Pharmaceuticals Inc | — | NEW | New buy |
| 33 | INSE | Inspired Entertainment Inc | — | NEW | New buy |
| 34 | LEN | Lennar Corp-a | — | NEW | New buy |
| 35 | LEN-B | Lennar CORP - B Shs | — | NEW | New buy |
| 36 | ELV | Elevance Health Inc | — | NEW | New buy |
| 37 | TGTX | Tg Therapeutics Inc | — | NEW | New buy |
| 38 | PDD | Pdd Holdings Inc | — | NEW | New buy |
| 39 | KNOP | KNOT Offshore Partners LP | — | NEW | New buy |
| 40 | CZR | Caesars Entertainment Inc | — | NEW | New buy |
| 41 | SRPT | Sarepta Therapeutics Inc | — | NEW | New buy |
| 42 | XHR | Xenia Hotels & Resorts Inc | — | NEW | New buy |
| 43 | 2662247D | Iteos Therapeutics Inc | — | NEW | New buy |
| 44 | MREO | Mereo Biopharma Group Pl-adr | — | NEW | New buy |
| 45 | ASML | ASML Holding N.V. | — | NEW | New buy |
| 46 | HRMY | Harmony Biosciences Holdings | — | NEW | New buy |
| 47 | MRP | Millrose Properties | — | NEW | New buy |
| 48 | ZVRA | Zevra Therapeutics Inc | — | NEW | New buy |
| 49 | CRESY | Cresud S.a.-spons Adr | — | NEW | New buy |
| 50 | PHAT | Phathom Pharmaceuticals Inc | — | NEW | New buy |
According to official SEC Form 13F filings, 683 Capital Management, LLC reported a total U.S. public equity portfolio value of $2.0B across 127 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LLY, TSLA, COF) accounted for 18.5% of total reported equity market value during Q1 2025.
Top New Position Initiated
LLY
市值: $101.2M
During Q1 2025, 683 Capital Management, LLC's top holdings by market value included LLY (7.0%)、TSLA (6.1%)、COF (5.4%). The largest single position, LLY, represented 7.0% of total portfolio value.
In Q1 2025, 683 Capital Management, LLC made 127 total portfolio adjustments, initiating 127 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.